000 | 01918 a2200565 4500 | ||
---|---|---|---|
005 | 20250517082451.0 | ||
264 | 0 | _c20161114 | |
008 | 201611s 0 0 eng d | ||
022 | _a1475-2875 | ||
024 | 7 |
_a10.1186/s12936-016-1167-z _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aAwab, Ghulam Rahim | |
245 | 0 | 0 |
_aClinical trials of artesunate plus sulfadoxine-pyrimethamine for Plasmodium falciparum malaria in Afghanistan: maintained efficacy a decade after introduction. _h[electronic resource] |
260 |
_bMalaria journal _cFeb 2016 |
||
300 |
_a121 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAfghanistan _xepidemiology |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAntimalarials _xadministration & dosage |
650 | 0 | 4 |
_aArtemisinins _xadministration & dosage |
650 | 0 | 4 | _aArtesunate |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aChild, Preschool |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 |
_aDrug Resistance _xgenetics |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInfant |
650 | 0 | 4 |
_aMalaria, Falciparum _xdrug therapy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aPlasmodium falciparum _xdrug effects |
650 | 0 | 4 |
_aPyrimethamine _xadministration & dosage |
650 | 0 | 4 |
_aSulfadoxine _xadministration & dosage |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aImwong, Mallika | |
700 | 1 | _aPukrittayakamee, Sasithon | |
700 | 1 | _aAlim, Fazel | |
700 | 1 | _aHanpithakpong, Warunee | |
700 | 1 | _aTarning, Joel | |
700 | 1 | _aDondorp, Arjen M | |
700 | 1 | _aDay, Nicholas P J | |
700 | 1 | _aWhite, Nicholas J | |
700 | 1 | _aWoodrow, Charles J | |
773 | 0 |
_tMalaria journal _gvol. 15 _gp. 121 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1186/s12936-016-1167-z _zAvailable from publisher's website |
999 |
_c25771494 _d25771494 |